Related Experiment Videos
Renoprotection with vitamin D: specific for diabetic nephropathy?
1Universitäts-Kinderklinik, Department of Pediatrics, Marburg, Germany. klaus@med.uni-marburg.de
Abstract:
Zhang and co-workers report on the renoprotective role of the vitamin D receptor (VDR) in diabetic nephropathy using the method of streptozotocin-induced hyperglycemia in wild-type and VDR(-/-) mice. Also, experiments with cultured mesangial cells and podocytes confirm the effect of the active vitamin D metabolite 1,25(OH)(2)D(3) on inhibition of the renin-angiotensin system (RAS) in vitro. The authors conclude that the higher activation of the intrarenal RAS is the key factor to induce more severe diabetic nephropathy in VDR(-/-) mice.
Insights
The vitamin D receptor (VDR) protects kidneys in diabetic nephropathy. Loss of VDR worsens kidney damage by increasing the intrarenal renin-angiotensin system (RAS).
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetic nephropathy is a major complication of diabetes.
- The vitamin D receptor (VDR) plays a role in kidney health.
- The renin-angiotensin system (RAS) is implicated in kidney disease progression.
Discussion:
- This study investigates the renoprotective role of VDR in diabetic nephropathy.
- Experiments were conducted in wild-type and VDR knockout mice with streptozotocin-induced hyperglycemia.
- In vitro studies with mesangial cells and podocytes examined the effect of 1,25(OH)(2)D(3) on RAS.
Key Insights:
- VDR deficiency exacerbates kidney damage in diabetic nephropathy.
- The active vitamin D metabolite 1,25(OH)(2)D(3) inhibits the intrarenal RAS.
- Increased intrarenal RAS activation is a key factor in severe diabetic nephropathy in VDR(-/-) mice.
Outlook:
- Targeting VDR may offer a therapeutic strategy for diabetic nephropathy.
- Further research into the VDR-RAS interaction in diabetic kidney disease is warranted.
- Understanding these pathways could lead to novel treatments for diabetic complications.
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Chronic Kidney Disease III: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Antihypertensive Drugs: Direct Renin Inhibitors